Loading...
dock_to_right dock_to_right arrow_back

Terminology chevron_right Concepts chevron_right 1074691000202100

Production
add
1074691000202100
The component that hold information about this concept.
Product containing precisely dolutegravir (as dolutegravir sodium) 50 milligram and rilpivirine (as rilpivirine hydrochloride) 25 milligram/1 each conventional release oral tablet (clinical drug)
Dolutegravir (as dolutegravir sodium) 50 mg and rilpivirine (as rilpivirine hydrochloride) 25 mg oral tablet
900000000000073002 |Sufficiently defined by necessary conditions definition status (core metadata concept)|
Specifies if the concept version is primitive or defined. Set to a descendant of 900000000000444006

Product containing precisely dolutegravir (as dolutegravir sodium) 50 milligram and rilpivirine (as rilpivirine hydrochloride) 25 milligram/1 each conventional release oral tablet (clinical drug)

SCTID: 1074691000202100, Defined, Active


1074691000202100|Product containing precisely dolutegravir (as dolutegravir sodium) 50 milligram and rilpivirine (as rilpivirine hydrochloride) 25 milligram/1 each conventional release oral tablet (clinical drug)|
  • en Dolutegravir (as dolutegravir sodium) 50 mg and rilpivirine (as rilpivirine hydrochloride) 25 mg oral tablet
  • en Product containing precisely dolutegravir (as dolutegravir sodium) 50 milligram and rilpivirine (as rilpivirine hydrochloride) 25 milligram/1 each conventional release oral tablet (clinical drug)

1074691000202100 |Product containing precisely dolutegravir (as dolutegravir sodium) 50 milligram and rilpivirine (as rilpivirine hydrochloride) 25 milligram/1 each conventional release oral tablet (clinical drug)|

=== 421026006 |Conventional release oral tablet (dose form)| +
    732936001 |Tablet (unit of presentation)| +
    779051001 |Product containing only dolutegravir and rilpivirine in oral dose form (medicinal product form)| :
        { 732943007 |Has basis of strength substance (attribute)| = 703123005 |Rilpivirine (substance)|,
          762949000 |Has precise active ingredient (attribute)| = 703124004 |Rilpivirine hydrochloride (substance)|,
          732947008 |Has presentation strength denominator unit (attribute)| = 732936001 |Tablet (unit of presentation)|,
          732945000 |Has presentation strength numerator unit (attribute)| = 258684004 |Milligram (qualifier value)| }
        { 732943007 |Has basis of strength substance (attribute)| = 713464000 |Dolutegravir (substance)|,
          762949000 |Has precise active ingredient (attribute)| = 713465004 |Dolutegravir sodium (substance)|,
          732947008 |Has presentation strength denominator unit (attribute)| = 732936001 |Tablet (unit of presentation)|,
          732945000 |Has presentation strength numerator unit (attribute)| = 258684004 |Milligram (qualifier value)| }
Active

11793731000202117 - Dolutegravir (as dolutegravir sodium) 50 mg and rilpivirine (as rilpivirine hydrochloride) 25 mg oral tablet (en) View

11793731000202117
en
Synonym (core metadata concept)
Dolutegravir (as dolutegravir sodium) 50 mg and rilpivirine (as rilpivirine hydrochloride) 25 mg oral tablet
900000000000448009 |Entire term case insensitive (core metadata concept)|
Preferred
True

11777911000202112 - Product containing precisely dolutegravir (as dolutegravir sodium) 50 milligram and rilpivirine (as rilpivirine hydrochloride) 25 milligram/1 each conventional release oral tablet (clinical drug) (en) View

11777911000202112
en
Fully specified name (core metadata concept)
Product containing precisely dolutegravir (as dolutegravir sodium) 50 milligram and rilpivirine (as rilpivirine hydrochloride) 25 milligram/1 each conventional release oral tablet (clinical drug)
900000000000448009 |Entire term case insensitive (core metadata concept)|
Preferred
True

Relationship (15674178025) - 1074691000202100 -> 788073005 (766939001) View

766939001 |Plays role (attribute)|
788073005 |Antiretroviral therapeutic role (role)|
0
900000000000011006 |Inferred relationship (core metadata concept)|
False

Relationship (15674174028) - 1074691000202100 -> 779051001 (116680003) View

116680003 |Is a (attribute)|
779051001 |Product containing only dolutegravir and rilpivirine in oral dose form (medicinal product form)|
0
900000000000011006 |Inferred relationship (core metadata concept)|
True

Relationship (15674175027) - 1074691000202100 -> 421026006 (411116001) View

411116001 |Has dose form (attribute)|
421026006 |Conventional release oral tablet (dose form)|
0
900000000000011006 |Inferred relationship (core metadata concept)|
True

Relationship (15674176026) - 1074691000202100 -> 732936001 (763032000) View

763032000 |Has unit of presentation (attribute)|
732936001 |Tablet (unit of presentation)|
0
900000000000011006 |Inferred relationship (core metadata concept)|
True

Relationship (15674179022) - 1074691000202100 -> 703124004 (762949000) View

762949000 |Has precise active ingredient (attribute)|
703124004 |Rilpivirine hydrochloride (substance)|
1
900000000000011006 |Inferred relationship (core metadata concept)|
True

Relationship (15674180020) - 1074691000202100 -> 703123005 (732943007) View

732943007 |Has basis of strength substance (attribute)|
703123005 |Rilpivirine (substance)|
1
900000000000011006 |Inferred relationship (core metadata concept)|
True

Relationship (15674182028) - 1074691000202100 -> 258684004 (732945000) View

732945000 |Has presentation strength numerator unit (attribute)|
258684004 |Milligram (qualifier value)|
1
900000000000011006 |Inferred relationship (core metadata concept)|
True

Relationship (15674184027) - 1074691000202100 -> 732936001 (732947008) View

732947008 |Has presentation strength denominator unit (attribute)|
732936001 |Tablet (unit of presentation)|
1
900000000000011006 |Inferred relationship (core metadata concept)|
True

Relationship (15674185026) - 1074691000202100 -> 713465004 (762949000) View

762949000 |Has precise active ingredient (attribute)|
713465004 |Dolutegravir sodium (substance)|
2
900000000000011006 |Inferred relationship (core metadata concept)|
True

Relationship (15674186025) - 1074691000202100 -> 713464000 (732943007) View

732943007 |Has basis of strength substance (attribute)|
713464000 |Dolutegravir (substance)|
2
900000000000011006 |Inferred relationship (core metadata concept)|
True

Relationship (15674188029) - 1074691000202100 -> 258684004 (732945000) View

732945000 |Has presentation strength numerator unit (attribute)|
258684004 |Milligram (qualifier value)|
2
900000000000011006 |Inferred relationship (core metadata concept)|
True

Relationship (15674190028) - 1074691000202100 -> 732936001 (732947008) View

732947008 |Has presentation strength denominator unit (attribute)|
732936001 |Tablet (unit of presentation)|
2
900000000000011006 |Inferred relationship (core metadata concept)|
True

779051001 View

779051001
Product containing only dolutegravir and rilpivirine in oral dose form (medicinal product form)
Dolutegravir and rilpivirine only product in oral dose form
900000000000073002 |Sufficiently defined by necessary conditions definition status (core metadata concept)|
True

421026006 View

421026006
Conventional release oral tablet (dose form)
Oral tablet
900000000000073002 |Sufficiently defined by necessary conditions definition status (core metadata concept)|
True

732936001 View

732936001
Tablet (unit of presentation)
Tablet
900000000000074008 |Necessary but not sufficient concept definition status (core metadata concept)|
True
esc